• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 10 of 16 Results
Document Number k012371
 
 1 
 2 
 > 
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {Tina-quant Transferrin ver.2 (serum/plasma application)} 
CR260235 k012371 Transferrin General Chemistry MODERATE 05/06/2026
Roche Diagnostics, cobas c 303  {Tina-quant Transferrin ver.2} 
CR220436 K012371 Transferrin General Chemistry MODERATE 12/05/2022
Roche Diagnostics cobas c 503 analyzer  {TINA-QUANT TRANSFERRIN VER.2} 
CR200136 K012371 Transferrin General Chemistry MODERATE 04/10/2020
Roche Diagnostics cobas c 702 analyzer  
K100853 K012371 Transferrin General Chemistry MODERATE 09/01/2011
Roche Diagnostics cobas c 502 Analyzer  
K100853 K012371 Transferrin General Chemistry MODERATE 01/10/2011
Roche Diagnostics cobas c 701 analyzer  
K100853 K012371 Transferrin General Chemistry MODERATE 01/10/2011
Roche Diagnostics cobas c 311 Analyzer  {TINA-QUANT TRANSFERRIN VER.2} 
K012371 K012371 Transferrin General Chemistry MODERATE 02/19/2009
Roche Diagnostics Hitachi 917  {TINA-QUANT TRANSFERRIN VER.2} 
K012371 K012371 Transferrin General Chemistry MODERATE 09/21/2001
Roche Diagnostics Hitachi 704  {TINA-QUANT TRANSFERRIN VER.2} 
K012371 K012371 Transferrin General Chemistry MODERATE 09/21/2001
Roche Diagnostics Hitachi 747  {TINA-QUANT TRANSFERRIN VER.2} 
K012371 K012371 Transferrin General Chemistry MODERATE 09/21/2001

-
-